Delivery Order SPE2DB20D3104-SPE2DB23FV7T0
Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,444 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561504603 Bupropion HCL XL 150 mg tablets. Under this order, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania by July 17, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Pharmaceutical Prime Vendor contract to provide...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $28,560 to Amerisourcebergen Drug Corporation for the supply of 4561731839 Bupropion HCL XL 150 mg tablets. Under this single award, Amerisourcebergen will deliver 90 tablets to a facility located in Conshohocken, Pennsylvania, with performance required from August 7-8, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's stockpile needs and...
- The Defense Logistics Agency awarded a $413.97 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 Bupropion HCL XL 150 mg tablets. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceuticals contract vehicle and will provide pharmaceutical products to support DLA and Department of Defense operations. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period concluding on September 25, 2023. No...
- The Defense Logistics Agency awarded a delivery order valued at $1,063.52 to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 150 mg tablets in quantities of 500 units. This contract, which was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 500 tablets of Bupropion HCL XL 150 mg. The contract has a total potential value of $2,209.29 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a $103,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561543623 Bupropion HCL XL 300mg tablets. Under this order, Amerisourcebergen will deliver 90 count bottles of the specified generic antidepressant medication to a facility in Conshohocken, Pennsylvania by July 20, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No subcontractors or set aside designations were identified....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Bupropion HCL XL 450 mg tablets (30-count) valued at $1,278.64. This non-set-aside, firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's headquarters and primary distribution point for federal...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $4,863.34 firm fixed price delivery order contract for the supply of 4,564,029,023 units of Bupropion HCL XL 150 mg tablets. The contract has a period of performance through March 21, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has an existing $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $37,884.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564205437 - Bupropion HCL XL 300 mg tablets in 500 count bottles. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $154.32 to Amerisourcebergen Drug Corp for the provision of 4561772818, Bupropion HCl XL 150 mg tablets, 90 count. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products from its facility located in Conshohocken, Pennsylvania to fulfill DLA's requirements. The single day period of performance from August 10-11, 2023 indicates this was likely an urgent, small-scale...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB23FV7T0Delivery Order
The Defense Logistics Agency awarded a $2,695.16 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561476405 Bupropion HCl XL 150 mg tablets. Under this order, Amerisourcebergen will deliver 90 tablets to a facility located in Conshohocken, Pennsylvania by July 13, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen likely supports DLA's stockpile of various prescription drugs for military treatment facilities worldwide. No subcontractors or set-aside designations were identified. This order represents a small value transaction under the DLA's portfolio of contracts for medical supplies.
Generated 12/24/23, 10:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/12/23 |